Mimedx Group, Inc.
A maker of regenerative medicine products that turn donated human placental and amniotic tissue into natural healing dressings used by doctors to treat chronic wounds and support surgical recovery. Its best-known brands include EPIFIX, EPICORD, and AMNIOFIX. The name blends "medical" and "Medx," and it was adopted in 2008 when a dormant Utah shell company merged with a Florida biomaterials startup to form the company now based in Marietta, Georgia. Amniotic tissue has actually been used to dress wounds for over a century—surgeons once even sewed "afterbirth" into patients before modern safety standards.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| Trigran Investments, Inc. | 13G/APassive | 4.2% | 6.16M | Feb 13, 2026 |
| Douglas T. Granat | 13G/APassive | 4.2% | 6.16M | Feb 13, 2026 |
| Lawrence A. Oberman | 13G/APassive | 4.2% | 6.16M | Feb 13, 2026 |
| Steven G. Simon | 13G/APassive | 4.2% | 6.16M | Feb 13, 2026 |
| Bradley F. Simon | 13G/APassive | 4.2% | 6.16M | Feb 13, 2026 |
| Steven R. Monieson | 13G/APassive | 4.2% | 6.16M | Feb 13, 2026 |